PhillipCapital

With a positive economic outlook, PhillipCapital is maintaining “overweight” on the Singapore banking sector, as loans remain on the path of recovery and interest rates are stable. 

iX Biopharma remains a “buy” for PhillipCapital analyst Tay Wee Kuang, with an unchanged target price of 44.5 cents, as the specialty pharmaceutical company announced that it has entered into a str

As the Straits Times Index (STI) turned in a “respectable performance” in the 1Q2021, PhillipCapital’s head of research Paul Chew writes that he remains positive on equity markets, in an April 1 re

Phillip Securities, the brokerage arm of PhillipCapital, has launched a live currency conversion feature on its trading platform POEMS.

An expected recovery in the construction industry for 2021 has prompted PhillipCapital analyst Tan Jie Hui to initiate “buy” on Pan-United Corporation with a target price of 40 cents.

PhillipCapital’s research analyst Vivian Ye has identified three positive reasons for investors to invest in independent lubricant seller, United Global.

PhillipCapital analyst Tan Jie Hui has downgraded her recommendation on Yoma Strategic to “neutral” from “buy”, with a lower target price of 15.6 cents from 34 cents.

PhillipCapital has maintained its "buy" rating for Asian Pay Television Trust (APTT) with an unchanged target price of 15 cents following its 4QFY2020 results that were within expectation

PhillipCapital research analyst Yeap Jun Rong says he remains positive on the semiconductor sector’s long-term outlook, even as the sector is currently experiencing a global shortage at the moment.

Analysts from CGS-CIMB Research and PhillipCapital have maintained their respective “add” and “buy” calls for PropNex with increased target prices after the company’s 4QFY2020 results bea